Commission on Cancer
In 2014, LCMH was re-accredited by the Commission on Cancer (CoC), which means that a quality program of the American College of Surgeons, demonstrates a cancer program’s commitment to providing high-quality, multidisciplinary, patient-centered cancer care.
The CoC accreditation is nationally recognized by organizations, including the National Cancer Institute, Centers for Medicare & Medicaid Services, National Quality Forum, American Cancer Society, and The Joint Commission, as having established data-driven performance measures for the provision of quality cancer care.
The standards set the framework for a program that provides high-quality, patient-centered care and access to the full scope of cancer care services required to diagnose, treat, rehabilitate, and support. The Commission on Cancer (CoC), a program of the American College of Surgeons (ACoS), recognizes cancer care programs for their commitment to providing comprehensive, high-quality, and multidisciplinary patient centered care. The CoC is dedicated to improving survival and quality of life for cancer patients through standard-setting, prevention, research, education, and the monitoring of comprehensive quality care.
Lung Cancer Screening Center of Excellence
In 2015, LCMH was named a Screening Center of Excellence by the Lung Cancer Alliance (LCA) for its ongoing commitment to responsible lung cancer screening. Low dose CT screening for lung cancer carried out safely, efficiently and equitably saves tens of thousands of lives a year.
Designated Screening Centers of Excellence are committed to provide clear information based on current evidence on who is a candidate for lung cancer screening, and to comply with comprehensive standards based on best practices developed by professional bodies such as the American College of Radiology (ACR), the National Comprehensive Cancer Network (NCCN) and the International Early Lung Cancer Action Program (I-ELCAP) for controlling screening quality, radiation dose and diagnostic procedures within an experienced, multi-disciplinary clinical setting.
LCMH is one of only 10 hospitals in the state of Illinois to be designated as a Lung Cancer Screening Center of Excellence by the Lung Cancer Alliance. The screening consists of a low dose CT scan of the lungs to detect lung nodules. The purpose of this program is to screen people who are at high risk for lung cancer so that it can be identified in an early stage when effective treatment and cure are possible. To find out if you are a candidate and to register for this screening, or for more information, please call Little Company of Mary Hospital’s Health Education Center at 708.423.5774. No doctor’s order is required.